Herbal medicine as inducers of apoptosis in cancer treatment

Advanced Pharmaceutical Bulletin

Volumn 4, Issue SUPPL.1, 2014, Pages 421-427

  Safarzadeh, Elham ^a   Shotorbani, Siamak Sandoghchian ^a   Baradaran, Behzad ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti cancer compound; Apoptosis; Cancer; Herb drug interactions; Herbal medicine; Safety

Indexed keywords

7 HYDROXYSTAUROSPORINE; ALKALOID; BETA LAPACHONE; BIOCALEIN; COMBRETASTATIN; CURCUMIN; DOCETAXEL; EPIPODOPHYLLOTOXIN; ETOPOSIDE; FLAVONOID; FLAVOPIRIDOL; FLUOROURACIL; GENISTEIN; HERBACEOUS AGENT; LECTIN; NAVELBINE; PACLITAXEL; PHENOL; QUERCETIN; RESVERATROL; ROSCOVITINE; TAXANE DERIVATIVE; TENIPOSIDE; TERPENOID; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE; XANTHORRHIZOL;

ACUTE GRANULOCYTIC LEUKEMIA; ALLERGIC REACTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CATHARANTHUS ROSEUS; CELL CYCLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CHORIOCARCINOMA; COLON CANCER; COLORECTAL CANCER; DRUG ABSORPTION; DRUG APPROVAL; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; GINGER; HEAD AND NECK CANCER; HERBAL MEDICINE; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; KAPOSI SARCOMA; LIVER TOXICITY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHATIC LEUKEMIA; LYMPHOMA; MELIACEAE; MICROTUBULE; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PHARMACOLOGICAL BLOCKING; PODOPHYLLUM PELTATUM; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; TESTIS CANCER; VISCUM ALBUM; XANTHORRHIZA;

EID: 84906737375     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2014.062     Document Type: Review

References (46)

1. Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, et al. Natural compounds for cancer treatment and prevention. Pharmacol Res 2009;59(6):365-78.
2. Jena J. A Study on Natural Anticancer Plants. Int J Pharmaceut Chem Sci 2012;1(1):365-8.
3. Dhorajiya BD, Patel JR, Malani MH, Dholakiya BZ. Plant product (R)- Roscovitine valuable inhibitor of CDKs as An anti-cancer agent. Der Pharmacia Sinica 2012;3(1):131-43.
4. Tavakoli J, Miar S, Zadehzare MM, Akbari H. Evaluation of Effectiveness of Herbal Medication in Cancer Care: A Review Study. Iran J Cancer Prevent 2012;5(3):144-56.
5. Yang G, Li X, Li X, Wang L, Li J, Song X, et al. Traditional chinese medicine in cancer care: a review of case series published in the chinese literature. Evid Based Complement Alternat Med 2012;2012:751046.
6. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 2010;4(6):297-307.
7. Wang Z, Wang N, Chen J, Shen J. Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy. Evid Based Complement Alternat Med 2012;2012:873175.
8. Azadmehr A, Hajiaghaee R, Afshari A, Amirghofran Z, Refieian-Kopaei M, yousofi Darani H, et al. Evaluation of in vivo immune response activity and in vitro anti-cancer effect by Scrophularia megalantha. J Med Plants Res 2011;5(11):2365-8.
9. Pal SK, Shukla Y. Herbal medicine: current status and the future. Asian Pac J Cancer Prev 2003;4(4):281-8.
10. Smith-Hall C, Larsen HO, Pouliot M. People, plants and health: a conceptual framework for assessing changes in medicinal plant consumption. J Ethnobiol Ethnomed 2012;8:43.
11. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005;4(3):206-20.
12. Saklani A, Kutty SK. Plant-derived compounds in clinical trials. Drug Discov Today 2008;13(3-4):161-71.
13. Wang CZ, Calway T, Yuan CS. Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med 2012;40(4):657-69.
14. Naveen Kumar DR, Cijo George V, Suresh PK, Ashok Kumar R. Cytotoxicity, apoptosis induction and anti-metastatic potential of Oroxylum indicum in human breast cancer cells. Asian Pac J Cancer Prev 2012;13(6):2729-34.
15. Mukherjee AK, Basu S, Sarkar N, Ghosh AC. Advances in cancer therapy with plant based natural products. Curr Med Chem 2001;8(12):1467-86.
16. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005;100(1):72-9.
17. Yang HL, Chen CS, Chang WH, Lu FJ, Lai YC, Chen CC, et al. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett 2006;231(2):215-27.
18. Hemaiswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res 2006;20(4):239-49.
19. Junior DRRF, De Souza TP, Pires JG, Soares LA, De Araujo AA, Petrovick PR, et al. A dry extract of Phyllanthus niruri protects normal cells and induces apoptosis in human liver carcinoma cells. Exp Biol Med (Maywood) 2012;237(11):1281-8.
20. Taraphdar AK, Roy M, Bhattacharya RK. Natural products as inducers of apoptosis: Implication for cancer therapy and prevention. Curr Sci 2001;80(11):1387-96.
21. Wheat J, Currie G. Herbal medicine for cancer patients: An evidence based review. Int J Altern Med 2008;5(2).
22. Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, et al. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 2005;25(5):3293-302.
23. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998;92(3):996-1002.
24. Cheah YH, Nordin FJ, Tee TT, Azimahtol HL, Abdullah NR, Ismail Z. Antiproliferative property and apoptotic effect of xanthorrhizol on MDA-MB-231 breast cancer cells. Anticancer Res 2008;28(6A):3677-89.
25. Hwang JW, Oh JH, Yoo HS, Lee YW, Cho CK, Kwon KR, et al. Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-kappaB. Am J Chin Med 2012;40(1):187-202.
26. Guan XB, Sun Z, Chen XX, Wu HR, Zhang XY. Inhibitory effects of Zengshengping fractions on DMBA-induced buccal pouch carcinogenesis in hamsters. Chin Med J (Engl) 2012;125(2):332-7.
27. Yang S, Zhao Q, Xiang H, Liu M, Zhang Q, Xue W, et al. Antiproliferative activity and apoptosis-inducing mechanism of constituents from Toona sinensis on human cancer cells. Cancer Cell Int 2013;13(1):12.
28. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med (Maywood) 2002;227(1):20-5.
29. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999;18(44):6013-20.
30. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002;11(1):105-11.
31. Kamboj VP. Herbal medicine. Curr Sci India 2000;78(1):35-8.
32. Gratus C, Wilson S, Greenfield SM, Damery SL, Warmington SA, Grieve R, et al. The use of herbal medicines by people with cancer in the UK: a systematic review of the literature. QJM-Int J Med 2009;102(12):831-42.
33. Vickers A, Zollman C. Herbal medicine. BMJ 1999;319(7216):1050-3.
34. Treasure J. Herbal medicine and cancer: an introductory overview. Semin Oncol Nurs 2005;21(3):177-83.
35. Raghavendra HL, Yogesh HS, Gopalakrishna B, Chandrashekhar VM, Sathish kumar BP, Kumar V. An overview of herbal medicine. Int J Pharm Sci 2009;1(1):1-20.
36. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci 2005;78(5):431-41.
37. Jordan MA. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anticancer Agents 2002;2(1):1-17.
38. Duflos A, Kruczynski A, Barret JM. Novel aspects of natural and modified vinca alkaloids. Curr Med Chem Anticancer Agents 2002;2(1):55-70.
39. Perez EA. Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther 2009;8(8):2086-95.
40. Islam MN, Iskander MN. Microtubulin binding sites as target for developing anticancer agents. Mini Rev Med Chem 2004;4(10):1077-104.
41. Fauzee NJ. Taxanes: promising anti-cancer drugs. Asian Pac J Cancer Prev 2011;12(4):837-51.
42. Hagiwara H, Sunada Y. Mechanism of taxane neurotoxicity. Breast Cancer 2004;11(1):82-5.
43. Shoeb M. Anticancer agents from medicinal plants. Bangladesh J Pharmacol 2006;1:35-41.
44. Bent S, Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 2004;116(7):478-85.
45. Firenzuoli F, Gori L. Herbal medicine today: clinical and research issues. Evid Based Complement Alternat Med 2007;4(Suppl 1):37-40.
46. Rockwell S, Liu Y, Higgins SA. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat 2005;90(3):233-9.